In parallel, in accordance to previous reports that CD44 regulates Rho-family of GTPases to promote tumor progression [49–53], we show that SRGN promoted cytoskeleton reorganization via inducing Rac1 and CDC42 activation. The gene discussed is CD44; the disease is neoplasm.